ALBERT BOURLA - 27 Feb 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
27 Feb 2025
Net transactions value
+$3,545,577
Form type
4
Filing time
03 Mar 2025, 17:36:32 UTC
Previous filing
25 Feb 2025
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $18,248,188 +582,823 +167% $31.31 931,744 27 Feb 2025 Direct F1
transaction PFE Common Stock Tax liability $477,630 -18,300 -2% $26.10 913,444 27 Feb 2025 Direct F2
transaction PFE Common Stock Tax liability $14,224,981 -545,855 -60% $26.06 367,589 27 Feb 2025 Direct F3, F4
holding PFE Common Stock 5,357 27 Feb 2025 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -582,823 -100% $0.000000 0 27 Feb 2025 Common Stock 582,823 $31.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.